These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2142394)

  • 41. [Diagnosis and treatment of endometrial hyperplasia].
    Tanaka K; Yasuda M; Motizuki M; Sasaki T; Yamazaki T; Kurose T; Sasagawa M; Hando T; Ohmori M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1598-604. PubMed ID: 2525003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex steroid hormones and receptors in relation to S-phase fraction and ploidy level in endometrial carcinoma.
    Boman K; Mäentausta O; Bäckström T; Strang P; Stendahl U
    Anticancer Res; 1995; 15(3):999-1002. PubMed ID: 7645992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate].
    Tsumura I; Okamura Y; Takatsuka Y; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1509-12. PubMed ID: 2143889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The status of receptors in the management of endometrial cancer.
    Richardson GS; MacLaughlin DT
    Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683
    [No Abstract]   [Full Text] [Related]  

  • 45. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
    Okada H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of medroxyprogesterone acetate on the cell kinetics in primary breast cancer].
    Doihara H; Takashima S; Saeki H; Takiyama W; Kurita A; Soga H; Tanada M; Yokoyama N; Moriwaki S
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2057-62. PubMed ID: 2145805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.
    Amezcua CA; Zheng W; Muderspach LI; Felix JC
    Gynecol Oncol; 1999 Apr; 73(1):126-36. PubMed ID: 10094893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
    Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
    Morphol Igazsagugyi Orv Sz; 1985 Oct; 25(4):253-60. PubMed ID: 2933583
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hormone receptor status in adenomatous hyperplasia of the endometrium and endometrial carcinoma].
    Martin R; Lehmann E; Leitsmann H
    Zentralbl Gynakol; 1990; 112(16):1031-8. PubMed ID: 2220177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
    Husslein P; Egarter C; Eppel W; Salzer H; Spona J
    Zentralbl Gynakol; 1988; 110(20):1277-82. PubMed ID: 2977043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers].
    Wada T; Matunami N; Houjou T; Morikawa E; Mori N; Nakano K; Aizawa M; Kurooka K; Kadota K; Yamato M
    Gan To Kagaku Ryoho; 1989 May; 16(5):2087-92. PubMed ID: 2525004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The formulation of the current management of patients with atypical hyperplasia (AH)].
    Gorchev G; Milkov V; Popov I; Rachev E
    Akush Ginekol (Sofiia); 1993; 32(3):30-1. PubMed ID: 8037315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hormone receptors and endocrine therapy of renal carcinoma].
    Pizzocaro G; Piva L; Di Fronzo G; Ronchi E; Giongo A; Cozzoli A; Dormia E; Minervini S; Zanollo A; Fontanella U
    Ric Clin Lab; 1985; 15 Suppl 2():95-102. PubMed ID: 2937131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.
    Jääskeläinen J; Laasonen E; Kärkkäinen J; Haltia M; Troupp H
    Acta Neurochir (Wien); 1986; 80(1-2):35-41. PubMed ID: 2939693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of non-atypic endometrial hyperplasia using thermal balloon endometrial ablation therapy.
    Järvelä IY; Santala M
    Gynecol Obstet Invest; 2005; 59(4):202-6. PubMed ID: 15731561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapy with gestagens in hyperplastic changes of the endometrium].
    Griesinger R; Schindler AE
    Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):690-2. PubMed ID: 2948865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.
    Di Carlo F; Conti G; Giubertoni M; Muccioli G; Racca S
    Cancer Chemother Pharmacol; 1991; 27(4):271-7. PubMed ID: 1825621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats.
    Tas M; Kutuk MS; Serin IS; Ozgun MT; Oner G; Ozturk F
    Gynecol Endocrinol; 2013 Apr; 29(4):311-4. PubMed ID: 23305503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid receptors and response of ovarian cancer to hormones in vitro.
    Grönroos M; Kangas L; Mäenpää J; Vanharanta R; Nieminen AL; Johansson R
    Br J Obstet Gynaecol; 1984 May; 91(5):472-8. PubMed ID: 6232944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
    Quinn MA; Cauchi M; Fortune D
    Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.